Roche

#MEDIA - At #ARVO2026, we’re pleased to share promising data showing progress in preserving vision and managing complex retinal conditions. roche.com/media

¡Felicitaciones a la Cámara de Comercio de Quito por estos 120 años! En Roche compartimos esa visión de trabajo articulado y estamos convencidos de que la productividad y la innovación son motores clave para el bienestar del país. Es un gusto seguir construyendo juntos. 🇪🇨🤝 Ken del Equipo Roche

🏛️ 120 años no se construyen solos. Se construyen junto a quienes creen en el impacto, la innovación y el trabajo articulado por el desarrollo del país. 💼 Las palabras de Jessica Medina, de @Roche Ecuador, reflejan el valor de una institución que impulsa al sector productivo, representa sus intereses y genera espacios donde la empresa privada tiene voz y protagonismo. 🚀 Un reconocimiento que también proyecta futuro: seguir fortaleciendo la productividad, incidiendo en los espacios clave y acompañando el crecimiento de quienes mueven la economía del Ecuador. #ccq #SomosCCQ #120Años #Gremio #Empresas

We’re proud to announce our continued collaboration with the @wfhemophilia, through their Humanitarian Aid Program, working together to expand access to care for people with #haemophilia in locations where there is little to no access to treatment. Read more via their website: spkl.io/6015AfRCd #BleedingDisorders #PublicHealth #WFHCongress2026

Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc. For more details, click here ➡️ spkl.io/6011AfHJR $ROG $RHHBY #FinancialResults

#MEDIA - We’re pleased to share detailed, late-breaking results at #AANAM from two positive Phase III studies of our investigational oral, brain-penetrant medicine in relapsing multiple sclerosis. roche.com/media $RHHBY $ROP

#MEDIA - At #AANAM , we’re pleased to share new positive Phase III data in myelin oligodendrocyte glycoprotein antibody-associated disease (#MOGAD), a disease for which there are no approved treatments. roche.com/media $RHHBY $ROP

#MEDIA – We are pleased to announce that the US FDA has accepted Roche’s New Drug Application in #SystemicLupusErythematos. This important step moves us closer to providing a first-of-its-kind targeted treatment for people whose lives are significantly impacted by this debilitating autoimmune disease. roche.com/media/releases $ROG $RHHBY

Sequencing by expansion (SBX) is being designed to transform next-gen sequencing (NGS). Scientists will choose the best tool for their needs, adjust read lengths on one system, and handle small or large batches with ease. Discover how SBX is poised to revolutionize disease research. go.roche.com/xsbxflx #NGS #Genomics #Innovation #MakeSpaceWithSBX #RocheSBX

@ashesskhan Hi AshesKhan, thank you for reaching out! To ensure that you get the most relevant information, please visit this link and submit your request via the form medinfo.roche.com . Our specialised team will assist you. Kat at Team Roche

@Roche hi, I was looking for your tests, wanted to enquire about Onefoundation Cdx, cancer diagnostic test in pakistan. , went through your page and the email for contact is also invalid, please guide me.

@WBG_Health The scale of this gap requires more than just filling healthcare jobs; it demands a fundamental shift in how we deliver care. To build true system resilience, we must move beyond the hospital toward flexible, digital, and community-based models.

By 2030, the world is projected to face a shortfall of over 10M healthcare workers. Investing in healthcare isn’t just about improving health—it’s a pathway to creating jobs and building resilient health systems for the future. #HealthWorks Learn more: wrld.bg/owc650YJRgi

Diagnostics are the "intelligence" of health security. Roche is proud to join the Global One Health Diagnostics Access Compact to help expand access to reliable testing and build a more resilient tomorrow. Together, we can make the shift towards proactive care. #OneHealth #AMR

New CE‑marked blood test complements MRI with a simple, minimally invasive option for more regular monitoring of neuroinflammation‑related activity in adults diagnosed with RRMS, supporting earlier and better‑informed clinical management. roche.com/media $RHHBY $ROG

Roche's future sequencing by expansion (SBX) could revolutionize next-generation sequencing (NGS) with an unmatched combination of flexibility, speed & accuracy. SBX’s versatility allows for tailored approaches, benefiting scientists and labs with improved understanding of diseases. Step into this new era with SBX! go.roche.com/sbxaoflx #NGS #Genomics #Innovation #MakeSpaceWithSBX #RocheSBX

Dr. Tester F. Ashavaid acknowledged that, in one of their studies, more than 50% of patients receiving the standard dose were sub-therapeutic. Mass spectrometry can bridge this gap, supporting Therapeutic Drug Monitoring (TDM) to give clinicians precise, actionable insights. Read more: go.roche.com/xorgmskol #RocheMassSpec #TDM #Diagnostics

@IHB_Research A huge welcome to our IHB colleagues in their new home! 🏢 This state-of-the-art space in Basel is where the future of drug discovery takes shape. Proud to be on this journey together to revolutionize healthcare. #R&D #TeamIHB Ana at Roche Team

Unveiling Building 92 in #Basel for pioneering #HumanModelSystems! 🏢 Our new home is designed to break silos & make collaboration our default. With our @Roche colleagues, we’re aiming to revolutionise the future of R&D. Learn more 👉 roche.com/media/releases…

Strategic vision requires world-class infrastructure and implementation. We are proud to announce the inauguration of Building 92 in Basel—a pivotal milestone in Roche’s R&D evolution. As the new headquarters for @IHB_Research, B92 is more than a building; it is home to a multidisciplinary engine where we turn the potential of Human Model Systems into industry reality. Find out more 👉 spkl.io/6012A0poi

Hi Esma Thank you for getting in touch with us. Please submit your complaint via this contact form: accu-chek.com/contact as they will be able to support you best. Additionally, you can get in touch with our Diabetes Care office in your country to get additional guidance. Here is a link with a list of all our offices around the world: roche.com/about/business… Wishing you all the very best. Ana at Team Roche

@Roche nin accucheck cgm sine geceyim dedim Süresinden önce o sensör de bitti. Hatalı ölçümler gelmeye başladı ve bi şans daha vereyim dediğim de akşam taktığım sensor sabaha çıkmadı. Müşteri hizmetlerini aradım. 2 sini de göndereceğiz tekrar dediler. 2 diye fatura basılıp..

Cgm sensörlere nası güvencez? Bir de deli paralar ödeniyor 14-15 gün için ama yarı yolda kalıyoruz @FreeStyleLibre kullanıyorum 2 yıldır fakat 2 plusa geçtiğimden beri kullanım süresinden önce bitiyor ve ölçüm sonuçları çok farklı çıkıyor Cgm 6.5 olan ortalama hastanede 7.3 çıktı

#MEDIA - New survey demonstrates how diabetes limits day-to-day freedom for people around the world. The survey of 4,326 respondents revealed the significant mental and logistical burdens of managing diabetes, with 8 in 10 participants saying they would value predictive tools that for example can predict glucose changes before they occur. #DiabetesCare #MentalHealth #HealthTech $ROG $RHHBY

#MEDIA – We are pleased to share data from our phase III study in systemic lupus erythematosus, being presented today at #SLEuro and published in the @NEJM. This study highlights the potential of our therapy to effectively reduce disease activity for this potentially life-threatening autoimmune disease. 👉roche.com/media/releases $ROG $RHHBY

@gardp_amr Great news, thank you, @gardp_amr! By exchanging expertise and fostering dialogue, we can make meaningful strides towards combating antimicrobial resistance and advancing the development of innovative and life-saving antibiotics. Ken at Team Roche

🤝 GARDP and @Roche have signed an MoU to exchange expertise on advancing sustainable global access to innovative antibiotics. The dialogue will explore: 🌍 Access pathways for novel narrow-spectrum antibiotics 📋 Regulatory considerations 💊 Commercialization approaches that support affordability and appropriate use #AMR #GlobalHealth #AccessToMedicines